Xeltis
Employee Participants0
Total Rating0
Revenue$0
Developer of synthetic biodegradable heart valves and blood vessels. The company manufactures and develops fully bioabsorbable synthetic heart valves and vascular grafts that enable the patient's own body to naturally form a new heart valve through a therapeutic approach called Endogenous Tissue Restoration. With ETR, the patient's natural healing system develops tissue that pervades Xeltis' heart valve, forming a new, natural and fully functional valve within it. As ETR occurs, Xeltis implants are gradually absorbed by the body. Read More
Headquarters Seefeldstrasse 35, Zurich, 8008, CHE
Website www.xeltis.com
0/100